Press Releases and Blog
Blog
Big Pharma’s January Price Increases and Price Hikes on Popular Medications for Seniors Provide Reminder Drug Companies Set the Price
In case you missed it, Big Pharma kicked off the new year with price increases on hundreds of brand name drugs. These price hikes are
New Year, Same Fact: PBMs Play Critical Role Driving Down Health Costs
As Washington welcomes a new Congress, it’s a good time to revisit the critical, cost-saving role pharmacy benefit managers (PBMs) play in the prescription drug
STOP the Big Pharma “Delinking” Bailout
Misguided “Delinking” Legislation Would Hand Big Pharma a $32 Billion Bailout Paid for by Patients, Taxpayers, and Health Plan Sponsors, Including Small Businesses Congress is
National Survey Finds Employers Overwhelmingly Satisfied With PBMs’ Transparency, Flexibility, And Savings
Economist Report Confirms Value of PBMs A recent survey of nearly 700 employers across the country conducted by NORC at the University of Chicago found that
Reminder: “Delinking” Is Pharma’s Top Priority Because It Boosts Their Profits
Big Pharma’s number one priority for the lame duck is urging Congress to pass a disastrous “delinking” policy for the Medicare Part D program. The
Journal of Managed Care + Specialty Pharmacy (JMCP): It Is Time For A More Nuanced Discussion About PBMs
Commentary published in the Journal of Managed Care + Specialty Pharmacy (JMCP) by Susan A. Cantrell, MHL, RPh, CAE, CEO of Academy of Managed Care Pharmacy (AMCP) defends
Press Releases
California Wildfire Resources
During a natural disaster, access to healthcare can be challenging and there may be disruptions for people trying to obtain their medications. PCMA created this
PCMA Statement On Released Text Of Continuing Resolution
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on the inclusion of substantial, misguided policies targeting prescription drug benefits, in
PCMA Statement On Pending Health Care Spending Package
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement: “The end-of-year health care package accompanying the Continuing Resolution has morphed into
PCMA Statement On Hawley-Warren Legislation
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott today issued the following statement: “With regards to the Hawley-Warren bill specifically,
PCMA Statement on Brian Thompson, UnitedHealthcare
Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement from JC Scott, President and CEO of PCMA: “On behalf of PCMA,
New Survey Finds Employers Overwhelmingly Satisfied With PBMs’ Transparency, Flexibility And Savings
Nine out of Ten Employers Think Their PBM is Transparent, 88 Percent Satisfied with PBMs’ Ability to Lower Rx Costs (Washington, D.C.) — PCMA today
Big Pharma’s January Price Increases and Price Hikes on Popular Medications for Seniors Provide Reminder Drug Companies Set the Price
In case you missed it, Big Pharma kicked off the new year with price increases on hundreds of brand name drugs. These price hikes are
New Year, Same Fact: PBMs Play Critical Role Driving Down Health Costs
As Washington welcomes a new Congress, it’s a good time to revisit the critical, cost-saving role pharmacy benefit managers (PBMs) play in the prescription drug
STOP the Big Pharma “Delinking” Bailout
Misguided “Delinking” Legislation Would Hand Big Pharma a $32 Billion Bailout Paid for by Patients, Taxpayers, and Health Plan Sponsors, Including Small Businesses Congress is
National Survey Finds Employers Overwhelmingly Satisfied With PBMs’ Transparency, Flexibility, And Savings
Economist Report Confirms Value of PBMs A recent survey of nearly 700 employers across the country conducted by NORC at the University of Chicago found that
Reminder: “Delinking” Is Pharma’s Top Priority Because It Boosts Their Profits
Big Pharma’s number one priority for the lame duck is urging Congress to pass a disastrous “delinking” policy for the Medicare Part D program. The
Journal of Managed Care + Specialty Pharmacy (JMCP): It Is Time For A More Nuanced Discussion About PBMs
Commentary published in the Journal of Managed Care + Specialty Pharmacy (JMCP) by Susan A. Cantrell, MHL, RPh, CAE, CEO of Academy of Managed Care Pharmacy (AMCP) defends
Big Pharma’s Latest Ad Binge A Critical Reminder: Policies Targeting PBMs Would Hand Drug Companies A Profit Windfall At The Expense Of Seniors And Taxpayers
Paragon Health Institute: Rebates Reduce Premiums, Warn Against Delinking Policy This week, Big Pharma launched yet another ad campaign urging Congress to pass proposals undermining
Stop Big Pharma’s Money Grab From America’s Seniors
As lawmakers return for the remainder of the 118th Congress, it will be critically important to reject Big Pharma’s self-described top year-end priority called “delinking,” which
PCMA Urges CMS to Stabilize the Medicare Part D Plan Marketplace
By Tim Dube, SVP, Policy and Regulatory Insights, Pharmaceutical Care Management Association Last week, PCMA offered recommendations to the Centers for Medicare and Medicaid Services
CMS Should Protect the Financial Health of Pharmacies When Implementing the IRA
By Tim Dube, SVP, Policy and Regulatory Insights, Pharmaceutical Care Management Association If the community pharmacy lobby is right, America’s Medicare beneficiaries may not be
